Happy to share that Dr. Lathan, CEO of AnthroTronix, will discuss the brand-new 510(k) FDA clearance of their DANA neurocognitive test at the 2014 SharpBrains Virtual Summit (October 28–30th), during the session Best practices to assess and enhance brain function via mobile devices and wearables.
Dr. Corinna Lathan leads AnthroTronix, a biomedical engineering product development company and pioneer in mobile platform technology. Their DANA™ product is a mobile medical app intended to collect and display performance information for use in the evaluation of patient brain function. Dr. Lathan has been recognized as one of Fast Company’s “Most Creative People in Business,” and as a Technology Pioneer and Young Global Leader by the World Economic Forum. She is actively involved in educational outreach programs that empower women and minorities in science and technology. Dr. Lathan is also on the Board of Engineering World Health.
–> Explore the Agenda @ 2014 SharpBrains Virtual Summit, and consider joining us October 28–30th!
To learn more about the FDA clearance announcement:
- Press release: AnthroTronix Receives FDA Clearance for Brain Health Assessment Tool
- FDA Clearance Letter of DANA™ as a “Recorder, Attention Task Performance”